Perry B, Doumas B T, Buffone G, Glick M, Ou C N, Ryder K
Clin Chem. 1986 Feb;32(2):329-32.
We used an enzymatic method for measuring total bilirubin in serum. Results by this method varied linearly with bilirubin concentrations to at least 300 mg/L. The day-to-day precision (CV) of the method ranged from less than 1% to about 11% at bilirubin concentrations of 183 and 12 mg/L, respectively. Commonly used anticoagulants, serum preparation materials, and selected drugs had no effect on the apparent bilirubin concentration, but turbidity caused a slight increase and hemoglobin concentrations of 2 g/L resulted in lower values, by as much as 17 mg/L at a bilirubin concentration of 95 mg/L. Patients' results obtained with this enzymatic method were slightly lower than those obtained with methods based on the Jendrassik-Grof principle. The largest differences, seen in samples with high "direct" bilirubin concentrations, can be decreased by measuring the absorbance at 425 nm instead of at 465 nm as recommended by the supplier of the bilirubin oxidase method.
我们采用酶法测定血清总胆红素。该方法的结果与胆红素浓度呈线性关系,至少在300mg/L范围内如此。在胆红素浓度分别为183mg/L和12mg/L时,该方法的日常精密度(CV)范围从小于1%至约11%。常用抗凝剂、血清制备材料和选定药物对表观胆红素浓度无影响,但浊度会导致轻微升高,血红蛋白浓度为2g/L时会使结果降低,在胆红素浓度为95mg/L时降低幅度高达17mg/L。用这种酶法获得的患者结果略低于基于Jendrassik-Grof原理的方法所获得的结果。在“直接胆红素 ”浓度高的样本中观察到的最大差异,可以通过按照胆红素氧化酶法供应商的建议,在425nm而不是465nm处测量吸光度来减小。